Dark

DYN
Dyne Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Sep 29, 2026 3:59:58 PM EDT

16.22USD-0.734%(-0.12)2,286,887

14.05Bid 18.35Ask 4.30Spread

Pre-market

Sep 28, 2026 9:28:30 AM EDT

15.95USD-2.387%(-0.39)0

After-hours

Sep 29, 2026 4:49:30 PM EDT

16.55USD+2.035%(+0.33)40,821

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.02B

Headquarters

Waltham, MA, USA

Industry

Biotechnology

Next Earnings

Nov 4, 2026 (36d)

AES CNP NRG ALE XLU

DYN Stats

Avg. Vol. 10 Day

2,848,158

Avg. Vol. 30 Day

2,883,336

Employees

2,489

Market Cap

3,024,358,450

Shares Out.

186,746,431

On/Off Exchange

55%/45%

6 Month Beta

1.59

1 Year Beta

2.04

2 Year Beta

1.72

3 Year Beta

1.72

52 Week Low

11.92

52 Week High

27.31

SMA50

23.14

SMA200

19.69

1 Week

-5.51%

1 Month

-35.40%

3 Month

-23.82%

6 Month

-5.24%

1 Year

+30.92%

2 Year

-54.91%

5 Year

-2.44%

Profile

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.

DYN Stock Summary

Dyne Therapeutics, Inc. Common Stock (NASDAQ:DYN) stock price today is $16.22, and today's volume is 2,286,887. DYN is down -0.734% today. The 30 day average volume is 2,883,336. DYN market cap is 3.02B with 186,746,431 shares outstanding.